ProcumbideCAS# 20486-27-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 20486-27-5 | SDF | Download SDF |
| PubChem ID | 21604824 | Appearance | Powder |
| Formula | C15H22O10 | M.Wt | 362.3 |
| Type of Compound | Iridoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2S,3R,4S,5S,6R)-2-[[(1aR,1bS,2S,5aS,6S,6aS)-5a,6-dihydroxy-1a-methyl-1b,2,6,6a-tetrahydrooxireno[1,2]cyclopenta[4,5-b]pyran-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol | ||
| SMILES | CC12C3C(OC=CC3(C(C1O2)O)O)OC4C(C(C(C(O4)CO)O)O)O | ||
| Standard InChIKey | UBAIOTDKPLIEDD-NTRJNKTHSA-N | ||
| Standard InChI | InChI=1S/C15H22O10/c1-14-9-13(22-3-2-15(9,21)10(20)11(14)25-14)24-12-8(19)7(18)6(17)5(4-16)23-12/h2-3,5-13,16-21H,4H2,1H3/t5-,6-,7+,8-,9-,10+,11+,12+,13+,14-,15+/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Procumbide has anti-inflammatory activity. |
| Targets | Immunology & Inflammation related |
Procumbide Dilution Calculator
Procumbide Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.7601 mL | 13.8007 mL | 27.6014 mL | 55.2029 mL | 69.0036 mL |
| 5 mM | 0.552 mL | 2.7601 mL | 5.5203 mL | 11.0406 mL | 13.8007 mL |
| 10 mM | 0.276 mL | 1.3801 mL | 2.7601 mL | 5.5203 mL | 6.9004 mL |
| 50 mM | 0.0552 mL | 0.276 mL | 0.552 mL | 1.1041 mL | 1.3801 mL |
| 100 mM | 0.0276 mL | 0.138 mL | 0.276 mL | 0.552 mL | 0.69 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 8-O-Acetyltorilolone
Catalog No.:BCN7094
CAS No.:20482-21-7
- Fmoc-Lys(ivDde)-OH
Catalog No.:BCC3520
CAS No.:204777-78-6
- Olcegepant
Catalog No.:BCC1818
CAS No.:204697-65-4
- Epitaraxerol
Catalog No.:BCN4677
CAS No.:20460-33-7
- Talnetant hydrochloride
Catalog No.:BCC1982
CAS No.:204519-66-4
- BCH
Catalog No.:BCC7993
CAS No.:20448-79-7
- Fmoc-β-Homo-Phe-OH
Catalog No.:BCC2629
CAS No.:204384-69-0
- NS 2028
Catalog No.:BCC6212
CAS No.:204326-43-2
- RS 45041-190 hydrochloride
Catalog No.:BCC5682
CAS No.:204274-74-8
- Oseltamivir phosphate
Catalog No.:BCC4690
CAS No.:204255-11-8
- Boc-Ser-OH.H2O
Catalog No.:BCC2599
CAS No.:204191-40-2
- Caesalmin E
Catalog No.:BCN7247
CAS No.:204185-91-1
- Nardosinonediol
Catalog No.:BCN8118
CAS No.:20489-11-6
- Curzerenone
Catalog No.:BCN3009
CAS No.:20493-56-5
- 3,7,4'-Trihydroxy-5-methoxy-8-prenylflavanone
Catalog No.:BCN1503
CAS No.:204935-85-3
- Talatisamine
Catalog No.:BCN5403
CAS No.:20501-56-8
- Lansiumarin A
Catalog No.:BCN4894
CAS No.:205115-73-7
- Lansiumarin C
Catalog No.:BCN4895
CAS No.:205115-75-9
- (+)-Peusedanol
Catalog No.:BCC9119
CAS No.:20516-23-8
- 2'-MeCCPA
Catalog No.:BCC7311
CAS No.:205171-12-6
- Isonardoperoxide
Catalog No.:BCN7628
CAS No.:205248-65-3
- DL-TBOA
Catalog No.:BCC5735
CAS No.:205309-81-5
- Amifostine
Catalog No.:BCC5232
CAS No.:20537-88-6
- Pinocembrin 7-O-(3'-galloyl-4',6'-(S)-hexahydroxydiphenoyl)-beta-D-glucose
Catalog No.:BCN6769
CAS No.:205370-59-8
Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund's adjuvant-induced arthritis in rats.[Pubmed:15120457]
J Ethnopharmacol. 2004 Apr;91(2-3):325-30.
The extract of Harpagophytum procumbens, widely utilized in Europe and, more recently, in other countries, is traditionally indicated to treat inflammatory processes. Harpagophytum procumbens acts by way of interleukins and leukocyte migration to the painful and inflamed joint area. Chemically, its secondary tuberous roots contains iridoid glycosides, harpagogide, Procumbide, and harpagoside, as the active principle. The purpose of the present study was evaluate the therapeutic potential as anti-inflammatory and analgesic agent in rat model of Freund's adjuvant-induced arthritis both in the acute and chronic phases. The animals were injected with Freund's adjuvant in sub-plantar tissue of the right posterior paw and randomly assigned in acute (25, 50, or 100 mg/kg) or chronic (100 mg/kg) treatments with Harpagophytum procumbens solution test or vehicle. Then, submitted to behavioral test and assessment of body weight and right paw's measurements. The results show that Harpagophytum procumbens extract increased the animals 'latency of paws' withdrawal, indicating a protective effect against the pain induced by the thermal stimulus, both in acute and chronic treatments. In addition to reduction in the right paw edema in the experimental groups when compared to control group. Thus, the data showed anti-inflammatory and peripheral analgesic properties of Harpagophytum procumbens extract with all doses tested, thus confirming its indication for inflammatory processes.
